SARS-Cov 2, a virus for rheumatologists
Main Article Content
Article Sidebar
Published
2020 October 30
Guillermo Sequera
https://orcid.org/0000-0002-7707-1363
How to Cite
1.
Sequera G. SARS-Cov 2, a virus for rheumatologists. Rev. parag. reumatol. [Internet]. 2020 Oct. 30 [cited 2026 Oct. 25];6(2):48-9. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/124
Downloads
Download data is not yet available.
Article Details
References
(1) Cohen J. From mice to monkeys, animals studied for coronavirus answers. Science (80-) [Internet]. 2020 Apr 17;368(6488):221 LP-222. Available from: http://science.sciencemag.org/content/368/6488/221.abstract
(2) Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct;69(40):1450–6.
(3) Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science (80- ) [Internet]. 2020 Oct 23;370(6515):eabd4570. Available from: http://science.sciencemag.org/content/370/6515/eabd4570.abstract
(4) Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H, et al. SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression. Reumatología Clinica 2020 Oct 16. doi: 10.1016/j.reumae.2020.08.001
(5) Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, et al. Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic. ACR open Rheumatol. 2020 Jun;2(6):335–43.
(6) Romão VC, Cordeiro I, Macieira C, Oliveira-Ramos F, Romeu JC, Rosa CM, et al. Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view. RMD open. 2020 Jun;6(2).
(2) Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct;69(40):1450–6.
(3) Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science (80- ) [Internet]. 2020 Oct 23;370(6515):eabd4570. Available from: http://science.sciencemag.org/content/370/6515/eabd4570.abstract
(4) Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H, et al. SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression. Reumatología Clinica 2020 Oct 16. doi: 10.1016/j.reumae.2020.08.001
(5) Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, et al. Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic. ACR open Rheumatol. 2020 Jun;2(6):335–43.
(6) Romão VC, Cordeiro I, Macieira C, Oliveira-Ramos F, Romeu JC, Rosa CM, et al. Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view. RMD open. 2020 Jun;6(2).
Section
EDITORIAL
How to Cite
1.
Sequera G. SARS-Cov 2, a virus for rheumatologists. Rev. parag. reumatol. [Internet]. 2020 Oct. 30 [cited 2026 Oct. 25];6(2):48-9. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/124
Share
